Skip to content

To explore the mechanism of Huoxin pill in the intervention of heart remodeling after PCI by clinical and multi-omics techniques

To explore the mechanism of Huoxin pill in the intervention of heart remodeling after PCI by clinical and multi-omics techniques

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076402
Enrollment
Unknown
Registered
2023-10-08
Start date
2023-10-08
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

Experimental group:Huoxin pill
Control group:placebo

Sponsors

The First Affiliated Hospital of Henan University of CM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. PCI meets the criteria of heart failure diagnosis and TCM syndrome differentiation; 2. Age 18-80 years old, gender is not limited; 3. Voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with shock, severe arrhythmia, acute myocardial infarction, pulmonary infarction, left ventricular outflow tract stenosis, infective endocarditis, pericardial tamponade, constrictive pericarditis; 2. With severe infection, serious liver (ALT= 3 times the upper limit of normal), kidney (Cr=3mg/dL or eGFR=60ml/min·1.73m2), electrolyte disorders, blood system and mental system and other serious primary diseases; 3. blood pressure (systolic blood pressure =180 mmHg and/or diastolic blood pressure =110 mmHg) and blood glucose (random blood glucose = 10.0mmol /L, glycosylated hemoglobin =8.0%) were not effectively controlled; 4. Pregnant and lactating women; 5. Patients with malignant tumors; 6. Allergy, or food allergy to a variety of drugs, or known to be allergic to the ingredients of heart pills; 7. Patients who cannot take care of themselves or take oral drugs; 8. Participate in other clinical researchers within one month; 9. Suspect or have a history of alcohol or drug abuse; 10. Researchers believe that other reasons are not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
New York Heart Association functional class;

Secondary

MeasureTime frame
Lee's heart failure score efficacy criteria;Evaluation of curative effect of TCM syndrome;6 minutes walking distance;Minnesota Heart Failure Quality of Life Survey Scale;

Countries

China

Contacts

Public ContactQiu Boyong

The First Affiliated Hospital of Henan University of CM

1057180884@qq.com+86 159 8187 4909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026